Company to present interim update from ENLIGHTED Phase 3 Study in LG UTUC following assessment of 50% of targeted total ...

Biotech is growing in North Carolina, and now one Triad college is stepping up to help train the workforce. Guilford Technical Community College is launching a ...

Wexner, who is chairman of the board and for whom the medical center is named, said that "probably the largest AI investment in the world will happen in Columbus" and predicted that "100 more" medical ...

Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the biotech’s shares for $8 apiece, representing a total deal value of $470 million.

Longevity Health Holdings has secured a temporary reprieve from Nasdaq delisting, but the clock is ticking as the ...

The Beachwood-based company announced on Tuesday, May 20, that it has appointed Dr. David Llewellyn as its new CEO and as a ...

SANOFI will acquire Vigil Neuroscience, a clinical-stage biotech company in a $470-million deal, the companies said on Thursday, as the French drugmaker seeks to boost its neurological pipeline ...

His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech ...

Despite these positive clinical developments, Amgen and Viking Therapeutics have performed poorly on the stock market in the past 12 months, though progress in this area might eventually help them ...

Greenhaven Road Capital, an investment management company, released its first-quarter 2025 investor letter. A copy of the ...

A BioSpace survey found that 56% of employed and 81% of unemployed respondents are considering jobs outside biopharma. Some ...

Artificial intelligence is undoubtedly impacting the biotech lifecycle, and presents myriad applications—and risks. Tim ...